首页> Blood> Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.

导出 OA

翻译打印收藏纠错

第一作者： Amina,Kariminia

第一单位： Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital/University of British Columbia, Vancouver, BC, Canada;

作者： Amina,Kariminia ^[1] ; Shernan G,Holtan ^[2] ; Sabine,Ivison ^[1] ; Jacob,Rozmus ^[1] ; Marie-Josée,Hebert ^[3] ; Paul J,Martin ^[4] ; Stephanie J,Lee ^[4] ; Daniel,Wolff ^[5] ; Peter,Subrt ^[1] ; Sayeh,Abdossamadi ^[1] ; Susanna,Sung ^[1] ; Jan,Storek ^[6] ; Megan,Levings ^[1] ; Mahmoud,Aljurf ^[7] ; Mukta,Arora ^[2] ; Corey,Cutler ^[8] ; Geneviève,Gallagher ^[9] ; John,Kuruvilla ^[10] ; Jeff,Lipton ^[10] ; Thomas J,Nevill ^[11] ; Laura F,Newell ^[12] ; Tony,Panzarella ^[10] ; Joseph,Pidala ^[13] ; Gizelle,Popradi ^[14] ; David,Szwajcer ^[15] ; Jason,Tay ^[16] ; Cynthia L,Toze ^[11] ; Irwin,Walker ^[17] ; Stephen,Couban ^[18] ; Barry E,Storer ^[4] ; Kirk R,Schultz ^[1]

作者单位： Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital/University of British Columbia, Vancouver, BC, Canada; ^[1] Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN; ^[2] Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, University of Montreal, Montreal, QC, Canada; ^[3] Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA; ^[4] Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; ^[5] University of Calgary, Calgary, AB, Canada; ^[6] King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; ^[7] Dana-Farber Cancer Institute, Boston, MA; ^[8] Centre Hospitalier Universitaire de Quebec, Hopital Enfant-Jesus, Quebec City, QC, Canada; ^[9] Princess Margaret Cancer Centre, Toronto, ON, Canada; ^[10] Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver General Hospital, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC, Canada; ^[11] Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health & Science University, Portland, OR; ^[12] H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; ^[13] McGill University Health Center, Montreal, QC, Canada; ^[14] CancerCare Manitoba, Winnipeg, MB, Canada; ^[15] Ottawa Hospital Research Institute, Ottawa, ON, Canada; ^[16] Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada; and. ^[17] Queen Elizabeth II Health Science Centre, Halifax, NS, Canada. ^[18]

医学主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);病例对照研究(Case-Control Studies);趋化因子CXCL10(Chemokine CXCL10);慢性病(Chronic Disease);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);人类(Humans);杀伤细胞, 天然(Killer Cells, Natural);男(雄)性(Male);中年人(Middle Aged);受体, CXCR3(Receptors, CXCR3)

DOI 10.1182/blood-2015-09-668251

PMID 27020088

发布时间 2021-02-02

基金项目

R01 CA108752/CA/NCI NIH HHS/United States U54 CA163438/CA/NCI NIH HHS/United States R01 CA118953/CA/NCI NIH HHS/United States K12 HD043488/HD/NICHD NIH HHS/United States U01 CA118953/CA/NCI NIH HHS/United States CIHR/Canada

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交